168 related articles for article (PubMed ID: 9032574)
1. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs.
Ruina M; Caselli M; Sartori S; Trevisani L; La Corte R; Trotta F; Alvisi V
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
Festen HP
Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
4. [Endoscopic study of digestive lesions caused by the use of nonsteroidal anti-inflammatory agents in rheumatic patients].
van Linthoudt D; Kocher F; Ott H
Schweiz Med Wochenschr; 1987 Apr; 117(16):604-8. PubMed ID: 3495881
[TBL] [Abstract][Full Text] [Related]
5. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
Larkai EN; Smith JL; Lidsky MD; Graham DY
Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
[TBL] [Abstract][Full Text] [Related]
6. NSAID, ulcers, and prostaglandins.
Kimmey MB
J Rheumatol Suppl; 1992 Nov; 36():68-73. PubMed ID: 1474538
[TBL] [Abstract][Full Text] [Related]
7. [Gastrointestinal damage in osteoarthritis patients].
Fuller R; Hirose-Pastor E; Levy M; Zaterka S; Massuda HB; Eisig JN; Yoshinari NH
Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):47-50. PubMed ID: 9435394
[TBL] [Abstract][Full Text] [Related]
8. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia].
Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL
Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
10. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
Lanza FL; Codispoti JR; Nelson EB
Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms of gastroduodenal mucosal damage in volunteers treated with nonsteroidal antiinflammatory drugs--the usefulness of prodrugs.
Yanagawa A; Fukumura T; Matsui H; Uemura H; Endo T; Nakagawa T; Mizushima Y
J Rheumatol; 1992 Jul; 19(7):1075-82. PubMed ID: 1512761
[TBL] [Abstract][Full Text] [Related]
12. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of NSAID-related gastroduodenal mucosal injury.
Aalykke C; Lauritsen K
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):705-22. PubMed ID: 11566036
[TBL] [Abstract][Full Text] [Related]
14. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
Wallace JL
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
[TBL] [Abstract][Full Text] [Related]
17. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
Aabakken L
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
[TBL] [Abstract][Full Text] [Related]
18. Validation of administrative data used for the diagnosis of upper gastrointestinal events following nonsteroidal anti-inflammatory drug prescription.
Abraham NS; Cohen DC; Rivers B; Richardson P
Aliment Pharmacol Ther; 2006 Jul; 24(2):299-306. PubMed ID: 16842456
[TBL] [Abstract][Full Text] [Related]
19. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
Laine L
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?
Dajani EZ
Am J Gastroenterol; 1996 May; 91(5):835-6. PubMed ID: 8633566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
